Do device start-ups that receive the highest market caps on IPO deliver the biggest rates of return to private investors? An analysis we've done (see chart below) seems to answer unequivocally yes.
We took device IPOs over the past two years and broke them out by range of post-money IPO valuations (greater...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?